Paper Details

  1. Home
  2. Paper Details

Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group.

Author: AllenC, DienerH C, PascualJ, PatelK, VegaP, VrijensF

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This randomized, double-blind study compared the efficacy and tolerability of rizatriptan and zolmitriptan in patients with migraine. Rizatriptan provided faster pain relief and had a lower incidence of photophobia and nausea.
Paper Details　
Original Abstract of the Article :
The efficacy and tolerability of rizatriptan (MAXALT) and zolmitriptan (ZOMIG) were compared in a randomized, double-blind, double-dummy, stratified (on prior use of rizatriptan and/or zolmitriptan), placebo-controlled, single attack study in 766 patients. Rizatriptan tended to provide freedom from ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1468-2982.2000.00069.x

データ提供：米国国立医学図書館（NLM）

Comparing the Effectiveness of Rizatriptan and Zolmitriptan for Migraines

The realm of headache research is constantly evolving as scientists seek to understand the causes and develop effective treatments for various types of headaches. This research focuses on migraine headaches, a common and often debilitating condition. It compares the effectiveness and tolerability of two migraine medications, rizatriptan and zolmitriptan, in a carefully designed clinical trial. The study provides valuable insights into the relative efficacy and safety profiles of these medications for treating migraine headaches.

A Comparative Look at Migraine Treatments: Rizatriptan vs. Zolmitriptan

The study revealed that both rizatriptan and zolmitriptan were effective in treating migraine headaches compared to a placebo. However, rizatriptan was found to provide faster pain relief and had a more favorable side effect profile than zolmitriptan. This suggests that rizatriptan may be a preferred option for patients seeking fast and effective migraine relief with minimal side effects.

Finding Relief in the Desert of Migraines: Choosing the Right Medication

Understanding the effectiveness and safety of different migraine medications is crucial for patients seeking relief. It's like choosing the right path in a vast desert; choosing a medication that is both effective and well-tolerated can make a significant difference in navigating this challenging journey. This study provides valuable information for patients and healthcare professionals seeking to make informed decisions about migraine treatment options.

Dr. Camel's Conclusion

This study provides a valuable comparison of two common migraine medications, highlighting the importance of choosing the right treatment based on individual needs and preferences. Finding the right medication can be like finding a refreshing oasis in a desert of migraine pain, providing much-needed relief and improving quality of life.

Date :
  1. Date Completed 2001-02-01
  2. Date Revised 2017-02-14
Further Info :

Pubmed ID

11037741

DOI: Digital Object Identifier

10.1046/j.1468-2982.2000.00069.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.